{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T22:24:39Z","timestamp":1779402279887,"version":"3.53.1"},"reference-count":120,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Hepatitis C virus (HCV) can cause a range of kidney diseases. HCV is the primary cause of mixed cryoglobulinaemia, which leads to cryoglobulinaemic vasculitis and cryoglobulinaemic glomerulonephritis (GN). Patients with acute cryoglobulinaemic vasculitis often exhibit acute kidney disease due to HCV infection, which typically progresses to acute kidney injury (AKI). HCV also increases the risk of chronic kidney disease (CKD) and the likelihood of developing end-stage renal disease (ESRD). Currently, direct-acting antiviral agents (DAAs) can be used to treat kidney disease at different stages. This review focuses on key findings regarding HCV and kidney disease, discusses the impact of DAAs, and highlights the need for further research and treatment.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1418301","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:24:52Z","timestamp":1719548692000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Understanding the relationship between HCV infection and progression of kidney disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Meiqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/13814788.2022.2056161","article-title":"Chronic hepatitis C: diagnosis and treatment made easy","volume":"28","author":"Abu-Freha","year":"2022","journal-title":"Eur. J. Gen. Pract."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.coviro.2017.04.007","article-title":"Functional RNA structures throughout the hepatitis C virus genome","volume":"24","author":"Adams","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5500\/wjt.v5.i1.19","article-title":"Conversion from Calcineurin inhibitors to Mtor inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant","volume":"5","author":"\u00c1lamo","year":"2015","journal-title":"World J. Transplant."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41564-022-01273-y","article-title":"Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis","volume":"8","author":"Ali","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0002-9343(83)90642-3","article-title":"Nephrotic syndrome and immune complex glomerulonephritis associated with chlorpropamide therapy","volume":"74","author":"Appel","year":"1983","journal-title":"Am. J. Med."},{"key":"ref7","first-page":"2022-vol3","article-title":"Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"Bahadoram","year":"2022","journal-title":"G. Ital. Nefrol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/00007890-200109270-00015","article-title":"Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality","volume":"72","author":"Baid","year":"2001","journal-title":"Transplantation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0041-1345(02)03060-9","article-title":"Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection","volume":"34","author":"Baid","year":"2002","journal-title":"Transplant. Proc."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jare.2016.07.004","article-title":"Hepatitis C and kidney disease: a narrative review","volume":"8","author":"Barsoum","year":"2017","journal-title":"J. Adv. Res."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.cgh.2013.03.018","article-title":"Acute kidney injury in patients with cirrhosis: perils and promise","volume":"11","author":"Belcher","year":"","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.3390\/ijms21113869","article-title":"Animal models used in hepatitis C virus research","volume":"21","author":"Berggren","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/liv.14672","article-title":"HCV cirrhotic patients treated with direct-acting antivirals: detection of tubular dysfunction and resolution after viral clearance","volume":"41","author":"Biliotti","year":"2021","journal-title":"Liver Int."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1097\/01.ASN.0000012382.97168.E0","article-title":"Association of Hepatitis C with Posttransplant diabetes in renal transplant patients on tacrolimus","volume":"13","author":"Bloom","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3389\/fimmu.2019.01198","article-title":"Autoreactive T-lymphocytes in inflammatory skin diseases","volume":"10","author":"Boehncke","year":"2019","journal-title":"Front. Immunol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"101575","DOI":"10.1016\/j.clinre.2020.11.005","article-title":"Hepatitis C virus-related vasculitis","volume":"45","author":"Boleto","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.akdh.2023.07.004","article-title":"Chronic kidney disease after liver transplantation","volume":"30","author":"Cabeza Rivera","year":"2023","journal-title":"Adv Kidney Dis Health"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1136\/gutjnl-2018-316234","article-title":"Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis","volume":"67","author":"Cacoub","year":"2018","journal-title":"Gut"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.jhep.2016.06.011","article-title":"Hepatitis C virus infection and chronic kidney disease: time for reappraisal","volume":"65","author":"Cacoub","year":"2016","journal-title":"J. Hepatol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cgh.2018.05.021","article-title":"Long-term efficacy of interferon-free antiviral treatment regimens in patients with hepatitis C virus-associated Cryoglobulinemia Vasculitis","volume":"17","author":"Cacoub","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"916361","DOI":"10.3389\/fphar.2022.916361","article-title":"Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: a brief, updated report","volume":"13","author":"Canonico","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000166850","article-title":"Immune complex disease complicating diabetic glomerulosclerosis","volume":"4","author":"Cavallo","year":"1984","journal-title":"Am. J. Nephrol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"109870","DOI":"10.1016\/j.diabres.2022.109870","article-title":"Hepatitis C virus infection and diabetes: a complex bidirectional relationship","volume":"187","author":"Ciardullo","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1038\/s41467-021-26744-4","article-title":"Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates","volume":"12","author":"Costa-Verdera","year":"2021","journal-title":"Nat. Commun."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2215\/CJN.03040322","article-title":"Acute kidney injury in patients with liver disease","volume":"17","author":"Cullaro","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S1590-8658(07)80004-1","article-title":"Mixed cryoglobulinemia: a model of virus-related disease in internal medicine","volume":"39","author":"Dammacco","year":"2007","journal-title":"Dig. Liver Dis."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/MCG.0b013e31822e8e12","article-title":"Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites","volume":"46","author":"de Carvalho","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"a036822","DOI":"10.1101\/cshperspect.a036822","article-title":"Hepatitis C virus structure: defined by what it is not","volume":"10","author":"Dearborn","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"10277","DOI":"10.3389\/ti.2022.10277","article-title":"Kidney transplantation from hepatitis-C Viraemic donors:considerations for practice in the United Kingdom","volume":"35","author":"Doherty","year":"2022","journal-title":"Transpl. Int."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"100677","DOI":"10.1016\/j.trre.2021.100677","article-title":"Hepatitis C virus and kidney transplantation: recent trends and paradigm shifts","volume":"36","author":"El Helou","year":"2022","journal-title":"Transplant. Rev."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/hep.1840360621","article-title":"Extrahepatic manifestations of hepatitis C among United States male veterans","volume":"36","author":"el-Serag","year":"2002","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"Electronic address, e.e.e., EASL recommendations on treatment of hepatitis C 2016","volume":"66","year":"2017","journal-title":"J. Hepatol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/pharmaceutics13040496","article-title":"Updated view on kidney transplant from Hcv-infected donors and Daas","volume":"13","author":"Fabrizi","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/pathogens8040176","article-title":"Direct-acting antiviral agents for HCV-associated glomerular disease and the current evidence","volume":"8","author":"Fabrizi","year":"","journal-title":"Pathogens"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.nefro.2021.01.009","article-title":"Acute kidney injury and chronic kidney disease after liver transplant: a retrospective observational study","volume":"42","author":"Fabrizi","year":"2022","journal-title":"Nefrologia"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/1319-2442.252918","article-title":"Hepatitis C virus-induced glomerular disease and posterior reversible encephalopathy syndrome after liver transplant: case report and literature review","volume":"30","author":"Fabrizi","year":"","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.14309\/ajg.0000000000001667","article-title":"Relapse of hepatitis C virus Cryoglobulinemic Vasculitis after sustained viral response after interferon-free direct-acting antivirals","volume":"117","author":"Fayed","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12882-021-02351-9","article-title":"Effect of omega-3 fatty acids supplementation on cardio-metabolic and oxidative stress parameters in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"22","author":"Fazelian","year":"2021","journal-title":"BMC Nephrol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"819320","DOI":"10.3389\/fmed.2022.819320","article-title":"Non HCV-related mixed Cryoglobulinemic Vasculitis with biopsy-proven renal involvement: the effects of rituximab","volume":"9","author":"Fenoglio","year":"2022","journal-title":"Front. Med."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","article-title":"Hepatitis C virus infects the endothelial cells of the blood-brain barrier","volume":"142","author":"Fletcher","year":"2012","journal-title":"Gastroenterology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0272-6386(96)90156-0","article-title":"High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis?","volume":"27","author":"Fornasieri","year":"1996","journal-title":"Am. J. Kidney Dis."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.289.10.1245-a","article-title":"Hepatitis C virus and atherosclerosis in patients with type 2 diabetes","volume":"289","author":"Fukui","year":"2003","journal-title":"JAMA"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000355615","article-title":"Hepatitis C infection is very rarely treated among hemodialysis patients","volume":"38","author":"Goodkin","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00000441-200108000-00001","article-title":"Prevalence of glomerulopathies in autopsies of patients infected with the hepatitis C virus","volume":"322","author":"Gopalani","year":"2001","journal-title":"Am. J. Med. Sci."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1158\/1055-9965.EPI-09-1275","article-title":"Risk for renal cell carcinoma in chronic hepatitis C infection","volume":"19","author":"Gordon","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ijms241210197","article-title":"Plasma pattern of extracellular vesicles isolated from hepatitis C virus patients and their effects on human vascular endothelial cells","volume":"24","author":"Grossini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.3748\/wjg.v27.i26.3984","article-title":"Acute kidney injury and Hepatorenal syndrome in cirrhosis","volume":"27","author":"Gupta","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.3389\/fimmu.2022.826732","article-title":"A deep insight into regulatory T cell metabolism in renal disease: facts and perspectives","volume":"13","author":"Han","year":"2022","journal-title":"Front. Immunol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e14200","DOI":"10.7717\/peerj.14200","article-title":"A retrospective study of prevalence and pattern of international consensus on ANA patterns among patients with hepatitis C virus infection","volume":"10","author":"Hsiao","year":"2022","journal-title":"PeerJ"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e2431","DOI":"10.1097\/MD.0000000000002431","article-title":"Impact of HCV infection on diabetes patients for the risk of end-stage renal failure","volume":"95","author":"Hwang","year":"2016","journal-title":"Medicine"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.kint.2018.06.011","article-title":"Executive summary of the 2018 KDIGO hepatitis C in CKD guideline: welcoming advances in evaluation and management","volume":"94","author":"Jadoul","year":"2018","journal-title":"Kidney Int."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12879-021-05991-2","article-title":"Impact of acute kidney injury on survival in patients with chronic hepatitis C: a retrospective cohort study","volume":"21","author":"Jeon","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/ki.1994.471","article-title":"Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy","volume":"46","author":"Johnson","year":"1994","journal-title":"Kidney Int."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"328","author":"Johnson","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"101331","DOI":"10.1016\/j.smim.2019.101331","article-title":"Complement dysregulation in glomerulonephritis","volume":"45","author":"Kaartinen","year":"2019","journal-title":"Semin. Immunol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/j.akdh.2023.11.002","article-title":"Liver disease-associated Glomerulopathies","volume":"31","author":"Kanduri","year":"2024","journal-title":"Adv Kidney Dis Health"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am. J. Transplant."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","article-title":"Acute kidney injury","volume":"7","author":"Kellum","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00109-007-0239-5","article-title":"Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection","volume":"85","author":"Kessenbrock","year":"2007","journal-title":"J. Mol. Med."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"15874","DOI":"10.1073\/pnas.2005477117","article-title":"Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury","volume":"117","author":"Kirita","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"980079","DOI":"10.3389\/fimmu.2022.980079","article-title":"Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment","volume":"13","author":"Kirou","year":"2022","journal-title":"Front. Immunol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00004836-199801000-00009","article-title":"Higher incidence of diabetes in liver transplant recipients with hepatitis C","volume":"26","author":"Knobler","year":"1998","journal-title":"J. Clin. Gastroenterol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2337\/dc05-1995","article-title":"Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis","volume":"29","author":"Lecube","year":"2006","journal-title":"Diabetes Care"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jhep.2022.01.029","article-title":"Metabolic dysfunction and cancer in HCV: shared pathways and mutual interactions","volume":"77","author":"Leslie","year":"2022","journal-title":"J. Hepatol."},{"key":"ref70","first-page":"296","article-title":"Hepatitis B and C virus infection in patients with systemic and cutaneous lupus erythematosus","volume":"45","author":"Lo Presti","year":"2022","journal-title":"New Microbiol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"703","DOI":"10.18502\/ijm.v13i5.7437","article-title":"Frequency and genotype distribution of hepatitis C virus infection in patients with diabetes type 2 in Ahvaz, Iran. Iranian","volume":"13","author":"Makvandi","year":"2021","journal-title":"J. Microbiol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/ijms17040562","article-title":"Nafld and chronic kidney disease","volume":"17","author":"Marcuccilli","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.kint.2022.07.012","article-title":"Executive summary of the KDIGO 2022 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"102","author":"Martin","year":"2022","journal-title":"Kidney Int."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jhep.2008.06.003","article-title":"Hepatitis C virus and kidney disease","volume":"49","author":"Martin","year":"2008","journal-title":"J. Hepatol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ndt\/gfr327","article-title":"Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome","volume":"27","author":"Mitwalli","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/BOR.0000000000000989","article-title":"Cryoglobulinemic vasculitis: a 2023 update","volume":"36","author":"Moretti","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/gut.2009.202317","article-title":"Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors","volume":"59","author":"Mostafa","year":"2010","journal-title":"Gut"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11892-013-0370-3","article-title":"Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection?","volume":"13","author":"Naing","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/ndt\/gfab281","article-title":"Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment","volume":"38","author":"Noris","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000319456","article-title":"Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis","volume":"32","author":"Noureddine","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0002-9343(83)90956-7","article-title":"Hematuria and red cell casts in typical diabetic nephropathy","volume":"74","author":"O'Neill","year":"1983","journal-title":"Am. J. Med."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney Int."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/gutjnl-2013-306102","article-title":"Cardiovascular diseases and HCV infection: a simple association or more?","volume":"63","author":"Petta","year":"2014","journal-title":"Gut"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00134-021-06454-7","article-title":"Acute kidney injury in the critically ill: an updated review on pathophysiology and management","volume":"47","author":"Pickkers","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/oxfordjournals.ndt.a027090","article-title":"Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units","volume":"11","author":"Pinto dos Santos","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1478-3231.2011.02458.x","article-title":"Hepatitis C virus and kidney: a strong association with different clinical aspects","volume":"31","author":"Pipili","year":"2011","journal-title":"Liver Int."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41581-018-0081-8","article-title":"Hepatitis C virus and the kidney","volume":"15","author":"Pol","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/bjh.17036","article-title":"Direct-acting antiviral agents for hepatitis C virus-mixed Cryoglobulinaemia: dissociated Virological and Haematological responses","volume":"191","author":"Pozzato","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10067-022-06391-w","article-title":"Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian study Group of Cryoglobulinemia (GISC)","volume":"42","author":"Quartuccio","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1002\/1529-0131(200012)43:12<2801::AID-ANR21>3.0.CO;2-V","article-title":"Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus","volume":"43","author":"Ramos-Casals","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ki.1995.82","article-title":"Secondary membranoproliferative glomerulonephritis","volume":"47","author":"Rennke","year":"1995","journal-title":"Kidney Int."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.medcli.2021.11.017","article-title":"Cryoglobulinemia","volume":"158","author":"Retamozo","year":"2022","journal-title":"Med. Clin."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","article-title":"Cryoglobulinaemia","volume":"4","author":"Roccatello","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000445841","article-title":"Improved (4 plus 2) rituximab protocol for severe cases of mixed Cryoglobulinemia: a 6-year observational study","volume":"43","author":"Roccatello","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000333775","article-title":"Treatment of hepatitis C virus infection after kidney transplantation. In: Morales JM, editor","volume":"176","author":"Rostaing","year":"2012","journal-title":"Contrib. Nephrol."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"102368","DOI":"10.1016\/j.dsx.2021.102368","article-title":"The nature and prognosis of renal diseases in chronic hepatitis-C-infected diabetic Egyptian patients: the role of renal biopsy","volume":"16","author":"Samaan","year":"2022","journal-title":"Diabetes Metab. Syndr."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jceh.2014.01.004","article-title":"Acute kidney dysfunction in patients with chronic hepatitis C virus infection: analysis of viral and non-viral factors","volume":"4","author":"Satapathy","year":"2014","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0140-6736(22)00461-5","article-title":"Acute glomerulonephritis","volume":"399","author":"Sethi","year":"2022","journal-title":"Lancet"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2215\/CJN.06760909","article-title":"Membranoproliferative glomerulonephritis secondary to monoclonal Gammopathy","volume":"5","author":"Sethi","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2337\/diacare.19.9.998","article-title":"High prevalence of hepatitis C virus infection in diabetic patients","volume":"19","author":"Sim\u00f3","year":"1996","journal-title":"Diabetes Care"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1681\/ASN.V114690","article-title":"High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy","volume":"11","author":"Soma","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000045243","article-title":"Focal segmental glomerular sclerosis among patients infected with hepatitis C virus","volume":"81","author":"Stehman-Breen","year":"1999","journal-title":"Nephron"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"a037093","DOI":"10.1101\/cshperspect.a037093","article-title":"Hepatitis C virus replication","volume":"10","author":"Tabata","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"E563","DOI":"10.1152\/ajpendo.00086.2017","article-title":"Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes","volume":"313","author":"Tang","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"201","DOI":"10.23736\/S0026-4806.20.07158-X","article-title":"Rheumatologic manifestations of hepatitis C virus","volume":"112","author":"Treppo","year":"2021","journal-title":"Minerva Med."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms19010023","article-title":"Hepatitis C virus: viral Quasispecies and genotypes","volume":"19","author":"Tsukiyama-Kohara","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/ard.58.10.630","article-title":"Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection","volume":"58","author":"Tzang","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fimmu.2018.00745","article-title":"Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT\/\u03b2-catenin pathway in chronic inflammation and oxidative stress during carcinogenesis","volume":"9","author":"Vall\u00e9e","year":"2018","journal-title":"Front. Immunol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"314","DOI":"10.4291\/wjgp.v7.i4.314","article-title":"Hepatitis C infection and renal cell carcinoma: a systematic review and meta-analysis","volume":"7","author":"Wijarnpreecha","year":"2016","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/0973-1482.82931","article-title":"Renal cell carcinoma and hepatitis C virus infection: is there any cause-outcome relationship?","volume":"7","author":"Wiwanitkit","year":"2011","journal-title":"J. Cancer Res. Ther."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 Hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1681\/ASN.V62220","article-title":"Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan","volume":"6","author":"Yamabe","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/v12050551","article-title":"Substitution of the CD81 binding site and \u03b2-Sandwich area in E2 of HCV in Cambodia","volume":"12","author":"Yamamoto","year":"2020","journal-title":"Viruses"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.transproceed.2009.03.069","article-title":"Association between chronic hepatitis C infection and coronary flow Reserve in Dialysis Patients with Failed Renal Allografts","volume":"41","author":"Yelken","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.jaut.2022.102871","article-title":"Lupus nephritis: new progress in diagnosis and treatment","volume":"132","author":"Yu","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12882-022-02985-3","article-title":"Successful treatment of infectious endocarditis-associated glomerulonephritis during active hepatitis C infection: a case report","volume":"23","author":"Zito","year":"2022","journal-title":"BMC Nephrol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1418301\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:24:58Z","timestamp":1719548698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1418301\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":120,"alternative-id":["10.3389\/fmicb.2024.1418301"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1418301","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"article-number":"1418301"}}